Results 151 to 160 of about 3,913,962 (299)

medicX-KG: a knowledge graph for pharmacists' drug information needs. [PDF]

J Biomed Semantics
Farrugia L, Azzopardi LM, Debattista J, Abela C.   +3 more
europepmc   +1 more source

Assessment of the scope, completeness, and consistency of various drug information resources related to COVID-19 medications in pregnancy and lactation. [PDF]

BMC Pregnancy Childbirth, 2023
Shareef J, Sridhar SB, Bhupathyraaj M, Shariff A, Thomas S, Salim Karattuthodi M.   +5 more
europepmc   +1 more source

Information and drug prices: evidence from the Medicare discount drug card program [PDF]

In early 2004, the U.S. Government initiated the Medicare Discount Drug Card Program (MDDCP), which created a market for drug cards that allowed elderly and handicapped subscribers to obtain discounts on their prescription drug purchases.
Emin M. Dinlersoz, Han Li, Roger Sherman, Rubén Hernández-Murillo   +3 more
core  

Cis‐regulatory and long noncoding RNA alterations in breast cancer – current insights, biomarker utility, and the critical need for functional validation

Molecular Oncology, EarlyView.
The noncoding region of the genome plays a key role in regulating gene expression, and mutations within these regions are capable of altering it. Researchers have identified multiple functional noncoding mutations associated with increased cancer risk in the genome of breast cancer patients.
Arnau Cuy Saqués, Aracele Martinez‐Mendez, John Crown, Alex Eustace   +3 more
wiley   +1 more source

Improving Online Drug Information: Insights from Quality Evaluation and Pharmaceutical System Design. [PDF]

Healthc Inform Res
Permatasari D, Syofyan, Yulianto AA, Qholbya W, Ridwan AA, Srangenge Y.   +5 more
europepmc   +1 more source

Barcoding drug information to recycle unwanted household pharmaceuticals: a review. [PDF]

Environ Chem Lett, 2022
Han J.
europepmc   +1 more source

Strength through diversity: how cancers thrive when clones cooperate

Molecular Oncology, EarlyView.
Intratumor heterogeneity can offer direct benefits to the tumor through cooperation between different clones. In this review, Kuiken et al. discuss existing evidence for clonal cooperativity to identify overarching principles, and highlight how novel technological developments could address remaining open questions.
Marije C. Kuiken, Maartje Witsen, Emile E. Voest, Krijn K. Dijkstra   +3 more
wiley   +1 more source

Artificial Intelligence as a Drug Information Resource: Limitations and Strategies to Optimize in Pharmacy Practice. [PDF]

Hosp Pharm
Soujah C, Bejjani C, Adra N, Blackburn L.   +3 more
europepmc   +1 more source

The Drug Manufacturer as a Drug Information Resource. [PDF]

J Pharm Technol, 2021
Nguyen C.
europepmc   +1 more source

Transcriptional network analysis of PTEN‐protein‐deficient prostate tumors reveals robust stromal reprogramming and signs of senescent paracrine communication

Molecular Oncology, EarlyView.
Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice, Jose I. Lopez, Aitziber Ugalde‐Olano, Maite Zufiaurre, Ianire Astobiza, Natalia Martin‐Martin, Laura Bozal‐Basterra, Saioa Garcia‐Longarte, Amaia Zabala‐Letona, Sofia Rey, Aida Santos‐Martin, Miguel Unda, Ana Loizaga‐Iriarte, Mariona Graupera, Paolo Nuciforo, Arkaitz Carracedo, Isabel Mendizabal   +16 more
wiley   +1 more source